Financial Relief for Cancer Patients Who Used Zantac or Ranitidine




If you or your loved one developed cancer symptoms after prolonged use of Zantac or ranitidine, you may be able claim personal injury compensation for medical bills, lost wages, pain, and suffering. If your loved one died of cancer after taking Zantac or ranitidine, you, as his or her next of kin, may be able to collect additional wrongful death compensation for the loss of your family member to support his or her dependent children. Wrongful death lawsuits collect burial expenses, a financial settlement for loss of the company of the deceased spouse or loss of guidance from a parent, and the loss of the wage earner's income escalated to his or her retirement age.

Federal Food and Drug Administration Recall


Pharmaceutical companies spend multimillions of dollars developing medications that benefit select patients even though others may experience side effects when taking it. The United States Food and Drug Administration only recalls drugs that endanger a large number of patients and may only require that the manufacturer warn the consumer of the possible dangerous side effects associated with their product. On April 1, 2020, Zantac and ranitidine were recalled by the FDA because the product deteriorates in the bottle releasing high levels of carcinogens. Drug stores stopped selling the defective antacid product.

Class Action Lawyers Seek Individual Personal Injury Clients


Law firms across the United States are seeking patients diagnosed with any of the following types of cancer after taking Zantac or ranitidine regularly for heartburn or gastroesophageal reflux disease (GERD). Our attorneys do not expect payment until they collect a personal injury settlement in your case. Cancers experienced by Zantac and ranitidine users include:

• Breast or lung cancer
• Cancer of the esophagus, liver, or pancreas
• Stomach or kidney cancer
• Prostate, colorectal, or bladder cancer

Voluntary Recall by Pharmaceutical Companies


Collective pharmaceutical manufacturers are powerful and wealthy with a net worth of trillions of dollars. Writing more than 15 million prescriptions for ranitidine annually, doctors unknowingly exposed their patients to NDMA which has also been found in water, milk, cheese, vegetables, and meat. Sanofi voluntarily recalled Zantac OTC sold in the United States and Canada due to “possible contamination with … [known carcinogen,] N-nitrosodimethylamine (NDMA).” Similarly, Apotex and Novartis recalled their ranitidine products sold as generic Zantac.

Defective Product Litigation


Currently, the debate in ranitidine and Zantac litigation is whether the NDMA found in the prodcut is introduced during the manufacturing process in another country where the FDA has less stringent control or whether the NDMA is the result of a design flaw in "unstable" ranitidine molecules. In either case, venture capital is a three-billion-dollar industry that funds research studies of defective products, pays expert witnesses, and finances class action lawsuits to benefit the average consumer.

Medical Malpractice Against Doctors and Medical Facilities


You may also be able to file a medical malpractice lawsuit against the doctor who prescribed Zantac or ranitidine for you. Your doctor may be held strictly liable for giving you the defective antacid medication. In May 2020, defendants argued in a Florida Court that there is no proof that ranitidine or Zantac causes cancer.

Zantac Lawsuit and Settlement


Sanofi, Boehringer, and Ingelheim manufactures Zantac, the first of their pharmaceuticals to generate $1 billion of revenue annually. Sanofi knew their medication possibly caused cancer and hid the facts from millions of consumers. NDMA is a highly carcinogenic byproduct of the ranitidine HCL. Stomach acid and body heat form NDMA as they interact with ranitidine HCL. Sanofi argues that NDMA was not easy to detect in their product and that the cancer risk was recently discovered. Studying animals exposed to NDMA, all of them developed cancer.

Joining Class Action Lawsuit


If you used Zantac and have not developed cancer, you can join a class action lawsuit against the manufacturers because they did not disclose the potentially harmful effects of their product. Wrongful death and personal injury claims are possible if you can prove that Zantac or ranitidine caused your cancer.

Law Firms With Resources to Stand Up to Pharmaceutical Manufacturers


Attorneys bring class action product liability lawsuits for all patients who suffered similarly from use of the defective medication. Consolidated Zantac lawsuits with 237 Zantac personal injury claims seek punitive damages because ranitidine and Zantac contain a million times more NMDA than the FDA considers safe. Plaintiffs claim that manufacturers knew ranitidine and Zantac contained carcinogens since the 1980s and continue to market their product as safe.




Other Featured Posts


How to Tell if You Qualify for COVID-19 Relief Assets from the Government

There's no question that COVID-19 has impacted almost everyone at this point, whether directly or indirectly. Some have had the misfortune of catching the virus and even dying from it, while others may...

READ MORE

Huge Class Action Suit Alert: Detained Migrants and Families Can Sue

On April 16, 2020, a California judge determined that a lawsuit against the Department of Homeland Security (DHS) and Immigration and Customs Enforcement (ICE) could continue. Many articles on the subject c...

READ MORE

Have an LG Refrigerator? A Settlement Might Be Waiting For You.

A class-action lawsuit that was filed against LG because of compressor failures in 31 different refrigerator models reached a settlement agreement on Aug. 14. The refrigerators include models with French or side...

READ MORE

ACLU Files Class-Action Lawsuit for the Use of Brute Force in Portland

ACLU Files Class-Action Lawsuit for the Use of Brute Force in Portland The nation has been under deep stress as protests overtake several cities and states in America. People are exercising their first...

READ MORE